EMILY HEYMANN: Open Payments
NPI 1518335223 · NASHVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$414 in 16 payments from 14 companies in 2025. Trend: 2023 $1,485 · 2024 $1,446 · 2025 $414
Food & beverage: $371Education: $43
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $72 |
| AstraZeneca Pharmaceuticals LP | 1 | $43 |
| GENZYME CORPORATION | 1 | $34 |
| Alexion Pharmaceuticals, Inc. | 1 | $31 |
| Janssen Biotech, Inc. | 1 | $29 |
| Daiichi Sankyo Inc. | 1 | $27 |
| Gilead Sciences, Inc. | 1 | $27 |
| Incyte Corporation | 1 | $27 |
| Celgene Corporation | 1 | $26 |
| Kite Pharma, Inc. | 1 | $25 |
Products named: Enhertu, EPKINLY, SARCLISA, ULTOMIRIS, TECVAYLI, Trodelvy, JAKAFI, REBLOZYL.
Industry payments across TN — which companies pay providers there.
